Banks play a critical role in the financial system, providing everything from commercial loans to wealth management and payment processing services. But concerns about loan losses and tightening regulations have tempered enthusiasm,
and over the past six months, the banking industry has pulled back by 5.8%. This performance was disappointing since the S&P 500 climbed 1.9%.
JPMorgan analyst maintains neutral rating for Flagstar Financial due to unfavorable migration in multifamily NPAs and skepticism around credit quality.
Check out this week's top-performing mid-cap stocks, including Akero Therapeutics' remarkable 106.57% surge following positive clinical trial results and other companies like Surgery Partners experiencing significant growth due to strategic developments.
Wall Street is struggling to find risk-on momentum, with major indexes stuck near the flatline at midday as investors assess the latest earnings reports from mega-cap tech stocks and weaker-than-expected U.S.
